Association Between Genetic Polymorphisms of CYP2D6 and Outcomes in Breast Cancer Patients With Tamoxifen Treatment
Association Between Genetic Polymorphisms of CYP2D6 and Outcomes in Breast Cancer Patients With Tamoxifen Treatment
The genetic polymorphisms of the cytochrome P450 may influence on the metabolism of tamoxifen.
The investigators want to
Inclusion Criteria:
Exclusion Criteria:
Jin-Gu, Busan , 614-735, South Korea
Saedaemoon-gu, Seoul 120-752, South Korea